Skip to main content
FinSpry Logo
FinSpry
CCCC logo
CCCC
(NASDAQ)
C4 Therapeutics, Inc.
$3.28-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

C4 Therapeutics (CCCC) Stock Price & Financial Analysis

C4 Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.14 - $3.39
52-Week High$3.82
52-Week Low$1.21
Open$3.16
Volume1.55M
Average Volume (3M)3.41M
Market Cap257.80M
Shares Outstanding82.89M
Price to Sales (P/S)7.17
Price to Book (P/B)1.00
EV/EBITDA-2.14
Revenue (TTM)35.95M
Net Income (TTM)-104.99M
Free Cash Flow (TTM)-99.30M
EPS (TTM)$-1.27
Profit Margin-292.08%
Operating Margin-320.53%
Return on Equity (ROE)-40.92%
Debt to Equity0.23
50-Day MA$2.85
200-Day MA$2.48
52-Week Change100.63%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About C4 Therapeutics

What is the current stock price for CCCC?

As of the latest trading session, CCCC stock trades at $3.28. The 52-week range is $1.21–$3.82, with a day range of $3.13–$3.38.

What is the P/E ratio for CCCC?

The P/E ratio (Price-to-Earnings) for CCCC is shown in the Key Statistics section. This valuation metric helps compare C4 Therapeutics, Inc. to industry peers.

Does CCCC pay dividends?

C4 Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CCCC?

Based on 2 analysts, the consensus for CCCC is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CCCC?

C4 Therapeutics's market capitalization is $271.9M, classifying it as a micro-cap company. C4 Therapeutics operates in the Healthcare sector within the Biotechnology industry.